# Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ponatinib-vs-imatinib-as-frontline-treatment-for-philadelphia-chromosome/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Josep‐María Ribera,Thibaud Prawitz,Andreas Freitag,Anuj Sharma,Balázs Dobi,Federica Rizzo,Lorenzo Sabatelli,Petros Patos |
| Citations | 16 |
| DOI | 10.1007/s12325-023-02497-y |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s12325-023-02497-y.pdf |
| OpenAlex ID | https://openalex.org/W4377116108 |
| PMID | 37208556 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Lorenzo Sabatelli](https://scholariq.org/researchers/lorenzo-sabatelli/)

## Paper journal

- [Advances in Therapy](https://scholariq.org/journals/advances-in-therapy/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.